Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Jul-24 8:07 PM View:  | Cytokinetics Inc. (CYTK) | 01-Jul-24 | Grant | 114 | -- | -- | < 1% 22.76K to 22.87K | |
| 16-May-24 5:59 PM View: | Cytokinetics Inc. (CYTK) | 15-May-24 | Grant | 5,600 | -- | -- | 33% 17.16K to 22.76K | |
| 03-Jan-24 4:29 PM View: | Cytokinetics Inc. (CYTK) | 02-Jan-24 | Grant | 74 | $84.12 | $6,224.88 | < 1% 17.08K to 17.16K | |
| 03-Oct-23 4:13 PM View: | Cytokinetics Inc. (CYTK) | 02-Oct-23 | Grant | 224 | $27.88 | $6,245.12 | 1% 16.86K to 17.08K | |
| 10-Jul-23 8:39 PM View: | Alkermes Plc. (ALKS) | 07-Jul-23 | Payment of Exercise | 1,430 | $29.88 | $42,728.40 | (4%) 33.03K to 31.6K | |
| 10-Jul-23 8:39 PM View: | Alkermes Plc. (ALKS) | 07-Jul-23 | Option Exercise | 5,957 | -- | -- | 22% 27.07K to 33.03K | |
| 05-Jul-23 4:26 PM View: | Cytokinetics Inc. (CYTK) | 03-Jul-23 | Grant | 187 | $33.36 | $6,238.32 | 1% 16.67K to 16.86K | 7% |
| 18-May-23 5:08 PM View: | Cytokinetics Inc. (CYTK) | 10-May-23 | Grant | 5,000 | -- | -- | 43% 11.67K to 16.67K | |
| 10-May-23 4:34 PM View: | Alkermes Plc. (ALKS) | 09-May-23 | Option Exercise | 41,250 | $31.13 | $1,284,110.00 | 152% 27.07K to 68.32K | |
| 10-May-23 4:34 PM View: | Alkermes Plc. (ALKS) | 09-May-23 | Planned Option Sale | 41,250 | $31.24 | $1,288,790.00 | (60%) 68.32K to 27.07K | |
| 05-Apr-23 4:02 PM View: | Cytokinetics Inc. (CYTK) | 03-Apr-23 | Grant | 149 | $37.71 | $5,618.79 | 1% 11.52K to 11.67K | (5%) |
| 04-Jan-23 6:42 PM View: | Cytokinetics Inc. (CYTK) | 03-Jan-23 | Grant | 126 | $44.35 | $5,588.10 | 1% 11.4K to 11.52K | |
| 05-Oct-22 4:25 PM View: | Cytokinetics Inc. (CYTK) | 03-Oct-22 | Grant | 110 | $51.11 | $5,622.10 | < 1% 11.29K to 11.4K | |
| 12-Jul-22 4:41 PM View: | Cytokinetics Inc. (CYTK) | 01-Jul-22 | Grant | 137 | $41.00 | $5,617.00 | 1% 11.15K to 11.29K | |
| 16-Jun-22 5:00 PM View: | Alkermes Plc. (ALKS) | 14-Jun-22 | Payment of Exercise | 695 | $27.19 | $18,897.10 | (3%) 27.77K to 27.07K | |
| 16-Jun-22 5:00 PM View: | Alkermes Plc. (ALKS) | 14-Jun-22 | Option Exercise | 7,585 | -- | -- | 38% 20.18K to 27.77K | |
| 11-May-22 6:07 PM View: | Cytokinetics Inc. (CYTK) | 10-May-22 | Grant | 5,000 | -- | -- | 81% 6.15K to 11.15K | |
| 01-Apr-22 7:17 PM View: | Cytokinetics Inc. (CYTK) | 01-Apr-22 | Grant | 146 | $38.38 | $5,603.48 | 2% 6.0K to 6.15K | (7%) |
| 04-Jan-22 4:48 PM View: | Cytokinetics Inc. (CYTK) | 03-Jan-22 | Grant | 122 | $46.00 | $5,612.00 | 2% 5.88K to 6.0K | 0% |
| 03-Dec-21 9:29 PM View: | Alkermes Plc. (ALKS) | 02-Dec-21 | Payment of Exercise | 1,339 | $22.11 | $29,605.30 | (6%) 21.52K to 20.18K | |
| 03-Dec-21 9:29 PM View: | Alkermes Plc. (ALKS) | 02-Dec-21 | Option Exercise | 5,578 | -- | -- | 35% 15.94K to 21.52K | |
| 04-Oct-21 7:04 PM View: | Cytokinetics Inc. (CYTK) | 01-Oct-21 | Grant | 153 | $36.74 | $5,621.22 | 3% 5.73K to 5.88K | 0% |
| 08-Jul-21 5:32 PM View: | Cytokinetics Inc. (CYTK) | 07-Jul-21 | Grant | 31 | $19.77 | $612.87 | < 1% 5.7K to 5.73K | 0% |
| 21-May-21 4:41 PM View: | Alkermes Plc. (ALKS) | 20-May-21 | Payment of Exercise | 1,404 | $21.92 | $30,775.70 | (8%) 17.35K to 15.94K | |
| 21-May-21 4:41 PM View: | Alkermes Plc. (ALKS) | 20-May-21 | Option Exercise | 6,104 | -- | -- | 54% 11.24K to 17.35K | |
| 13-May-21 8:04 PM View: | Cytokinetics Inc. (CYTK) | 12-May-21 | Grant | 5,000 | -- | -- | 1089% 0.46K to 5.46K | |
| 05-Apr-21 5:48 PM View: | Cytokinetics Inc. (CYTK) | 01-Apr-21 | Grant | 204 | $24.44 | $4,985.76 | 80% 0.26K to 0.46K | (< 1%) |
| 05-Jan-21 6:19 PM View: | Cytokinetics Inc. (CYTK) | 04-Jan-21 | Grant | 255 | $19.56 | $4,987.80 | 100% 0 to 0.26K | 0% |
| 25-Feb-20 5:15 PM View: | Alkermes Plc. (ALKS) | 24-Feb-20 | Market Purchase | 6,940 | $19.65 | $136,371.00 | 161% 4.3K to 11.24K | 9% |
| 12-Nov-19 4:41 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 6,274 | -- | -- | (100%) 6.27K to 0 | |
| 18-Mar-19 5:05 PM View: | Alkermes Plc. (ALKS) | 14-Mar-19 | Market Purchase | 445 | $33.06 | $14,711.70 | 12% 3.86K to 4.3K | (35%) |
| 18-Mar-19 5:05 PM View: | Alkermes Plc. (ALKS) | 21-Feb-19 | Market Purchase | 3,857 | $33.09 | $127,628.00 | 100% 0 to 3.86K | (35%) |
| 07-Feb-19 4:55 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 05-Feb-19 | Grant | 6,274 | -- | -- | 100% 0 to 6.27K | |
| 09-May-16 5:49 PM View: | Inovio Biomedical Corp. (INO) | 08-May-16 | Option Exercise | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 16-May-12 4:33 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-May-12 | Option Exercise | 180,000 | $39.64 | $7,134,610.00 | 558% 32.23K to 212.23K | |
| 16-May-12 4:33 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-May-12 | Market Option Sale (Planned) | 180,000 | $64.27 | $11,568,900.00 | (85%) 212.23K to 32.23K | (172%) |
| 09-May-12 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-May-12 | Option Exercise | 38,009 | $38.06 | $1,446,490.00 | 121% 31.39K to 69.4K | |
| 09-May-12 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-May-12 | Market Option Sale (Planned) | 33,009 | $62.10 | $2,049,900.00 | (48%) 69.4K to 36.39K | (181%) |
| 09-May-12 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 08-May-12 | Market Sale (Planned) | 5,000 | $62.10 | $310,506.00 | (14%) 36.39K to 31.39K | (181%) |
| 09-May-12 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-May-12 | Option Exercise | 142,695 | $39.40 | $5,621,970.00 | 392% 36.39K to 179.09K | |
| 09-May-12 4:40 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-May-12 | Market Option Sale (Planned) | 147,695 | $54.50 | $8,049,380.00 | (82%) 179.09K to 31.39K | (221%) |
| 06-Feb-12 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 02-Feb-12 | Grant | 14,501 | $0.01 | $145.01 | 66% 21.89K to 36.39K | |
| 23-Jan-12 4:38 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-Jan-12 | Market Sale (Planned) | 6,042 | $37.00 | $223,554.00 | (22%) 27.93K to 21.89K | (372%) |
| 13-Dec-11 5:22 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Dec-11 | Market Sale (Planned) | 5,000 | $28.90 | $144,500.00 | (15%) 32.94K to 27.93K | (505%) |
| 16-Nov-11 2:47 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 15-Nov-11 | Market Sale (Planned) | 606 | $29.77 | $18,040.60 | (2%) 33.54K to 32.94K | (487%) |
| 07-Feb-11 2:57 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-11 | Grant | 12,084 | $0.01 | $120.84 | 60% 20.0K to 32.08K | |
| 11-Dec-09 12:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Dec-09 | Grant | 20,000 | $0.01 | $200.00 | 100% 0 to 20.0K | |
| 02-Mar-09 5:05 PM View: | Endo Pharmaceuticals Holdin... (ENDP) | 26-Feb-09 | Grant | 13,054 | -- | -- | 100% 0 to 13.05K | |
| 25-Feb-08 5:15 PM View: | Endo Pharmaceuticals Holdin... (ENDP) | 21-Feb-08 | Grant | 4,466 | -- | -- | 100% 0 to 4.47K |